Royal Bank of Canada’s Principal Exchange-Traded Funds Principal Healthcare Innovators ETF BTEC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-986
| Closed | -$36K | – | 7714 |
|
|
2024
Q2 | $36K | Sell |
986
-3,113
| -76% | -$112K | ﹤0.01% | 5812 |
|
|
2024
Q1 | $156K | Buy |
4,099
+662
| +19% | +$24.6K | ﹤0.01% | 4893 |
|
|
2023
Q4 | $125K | Sell |
3,437
-50,992
| -94% | -$1.52M | ﹤0.01% | 5477 |
|
|
2023
Q3 | $1.64M | Sell |
54,429
-29,332
| -35% | -$985K | ﹤0.01% | 3030 |
|
|
2023
Q2 | $3.01M | Buy |
83,761
+54,571
| +187% | +$1.95M | ﹤0.01% | 2509 |
|
|
2023
Q1 | $969K | Buy |
29,190
+8,980
| +44% | +$313K | ﹤0.01% | 3365 |
|
|
2022
Q4 | $679K | Buy |
20,210
+6,164
| +44% | +$208K | ﹤0.01% | 3828 |
|
|
2022
Q3 | $482K | Sell |
14,046
-7,902
| -36% | -$287K | ﹤0.01% | 4066 |
|
|
2022
Q2 | $707K | Sell |
21,948
-49,012
| -69% | -$1.64M | ﹤0.01% | 3796 |
|
|
2022
Q1 | $2.85M | Sell |
70,960
-7,709
| -10% | -$305K | ﹤0.01% | 2737 |
|
|
2021
Q4 | $3.72M | Buy |
78,669
+5,941
| +8% | +$306K | ﹤0.01% | 2603 |
|
|
2021
Q3 | $3.97M | Buy |
72,728
+2,655
| +4% | +$150K | ﹤0.01% | 2486 |
|
|
2021
Q2 | $4.27M | Buy |
70,073
+633
| +0.9% | +$36.3K | ﹤0.01% | 2420 |
|
|
2021
Q1 | $4.02M | Sell |
69,440
-5,275
| -7% | -$330K | ﹤0.01% | 2407 |
|
|
2020
Q4 | $4.39M | Buy |
74,715
+1,648
| +2% | +$88.9K | ﹤0.01% | 2273 |
|
|
2020
Q3 | $3.48M | Buy |
+73,067
| New | +$3.32M | ﹤0.01% | 2253 |
|
Royal Bank of Canada's BTEC Position: Q3 2024 in Review
Royal Bank of Canada sold out of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) in Q3 2024, closing a stake of 986 shares — an estimated $36K sold.
Royal Bank of Canada first reported a position in BTEC in Q3 2020 and held it in 16 quarters. The position peaked at $4.39M in Q4 2020. 0 funds tracked by Wall St. Rank hold BTEC as of Q3 2024.
- Royal Bank of Canada reported no remaining Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position as of Q3 2024 after selling out during the quarter.
- Royal Bank of Canada sold 986 Principal Exchange-Traded Funds Principal Healthcare Innovators ETF shares in Q3 2024, an estimated $36K.
- Royal Bank of Canada first reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in Q3 2020 and held it in 16 quarters.
- Royal Bank of Canada's Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position peaked at $4.39M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF as of Q3 2024.
Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.